134 related articles for article (PubMed ID: 38054838)
1. Whole-Body Muscle Magnetic Resonance Imaging in 81 Patients with Spinal and Bulbar Muscular Atrophy: A Prospective Study.
Kim H; Seo I; Kang M; Park JM; Seok HY; Kim S; Park JS
Ann Neurol; 2024 Mar; 95(3):596-606. PubMed ID: 38054838
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity.
Klickovic U; Zampedri L; Sinclair CDJ; Wastling SJ; Trimmel K; Howard RS; Malaspina A; Sharma N; Sidle K; Emira A; Shah S; Yousry TA; Hanna MG; Greensmith L; Morrow JM; Thornton JS; Fratta P
Neurology; 2019 Aug; 93(9):e895-e907. PubMed ID: 31391248
[TBL] [Abstract][Full Text] [Related]
3. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments.
Dahlqvist JR; Oestergaard ST; Poulsen NS; Thomsen C; Vissing J
Neurology; 2019 Feb; 92(6):e548-e559. PubMed ID: 30610091
[TBL] [Abstract][Full Text] [Related]
4. Disease progression and outcome measures in spinobulbar muscular atrophy.
Dahlqvist JR; Fornander F; de Stricker Borch J; Oestergaard ST; Poulsen NS; Vissing J
Ann Neurol; 2018 Nov; 84(5):754-765. PubMed ID: 30255951
[TBL] [Abstract][Full Text] [Related]
5. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.
Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B
Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI findings of X-linked spinal and bulbar muscular atrophy.
Hamano T; Mutoh T; Hirayama M; Kawamura Y; Nagata M; Fujiyama J; Kuriyama M
J Neurol Sci; 2004 Jul; 222(1-2):93-7. PubMed ID: 15240202
[TBL] [Abstract][Full Text] [Related]
7. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients.
Brogna C; Cristiano L; Verdolotti T; Pichiecchio A; Cinnante C; Sansone V; Sconfienza LM; Berardinelli A; Garibaldi M; Antonini G; Pane M; Pera MC; Antonaci L; Ficociello L; Albamonte E; Tasca G; Begliuomini C; Tartaglione T; Maggi L; Govoni A; Comi G; Colosimo C; Mercuri E
J Neurol; 2020 Apr; 267(4):898-912. PubMed ID: 31776722
[TBL] [Abstract][Full Text] [Related]
8. Skeletal Muscle Magnetic Resonance Imaging of the Lower Limbs in Late-onset Lipid Storage Myopathy with Electron Transfer Flavoprotein Dehydrogenase Gene Mutations.
Liu XY; Jin M; Wang ZQ; Wang DN; He JJ; Lin MT; Fu HX; Wang N
Chin Med J (Engl); 2016 Jun; 129(12):1425-31. PubMed ID: 27270537
[TBL] [Abstract][Full Text] [Related]
9. Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA).
Hashizume A; Fischbeck KH; Pennuto M; Fratta P; Katsuno M
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1085-1091. PubMed ID: 32934110
[TBL] [Abstract][Full Text] [Related]
10. Muscle magnetic resonance imaging in spinal muscular atrophy type 3: Selective and progressive involvement.
Durmus H; Yilmaz R; Gulsen-Parman Y; Oflazer-Serdaroglu P; Cuttini M; Dursun M; Deymeer F
Muscle Nerve; 2017 May; 55(5):651-656. PubMed ID: 27543937
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial.
Grunseich C; Miller R; Swan T; Glass DJ; El Mouelhi M; Fornaro M; Petricoul O; Vostiar I; Roubenoff R; Meriggioli MN; Kokkinis A; Guber RD; Budron MS; Vissing J; Soraru G; Mozaffar T; Ludolph A; Kissel JT; Fischbeck KH;
Lancet Neurol; 2018 Dec; 17(12):1043-1052. PubMed ID: 30337273
[TBL] [Abstract][Full Text] [Related]
12. The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.
Rosenbohm A; Hirsch S; Volk AE; Grehl T; Grosskreutz J; Hanisch F; Herrmann A; Kollewe K; Kress W; Meyer T; Petri S; Prudlo J; Wessig C; Müller HP; Dreyhaupt J; Weishaupt J; Kubisch C; Kassubek J; Weydt P; Ludolph AC
J Neurol; 2018 May; 265(5):1026-1036. PubMed ID: 29464380
[TBL] [Abstract][Full Text] [Related]
13. Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot study.
Otto LAM; Froeling M; van Eijk RPA; Asselman FL; Wadman R; Cuppen I; Hendrikse J; van der Pol WL
NMR Biomed; 2021 Apr; 34(4):e4473. PubMed ID: 33480130
[TBL] [Abstract][Full Text] [Related]
14. The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA).
Blasi L; Sabbatini D; Fortuna A; Querin G; Martinelli I; Vianello S; Bertolin C; Pareyson D; Pennuto M; Pegoraro E; Bello L; Sorarù G
Sci Rep; 2023 Oct; 13(1):17311. PubMed ID: 37828349
[TBL] [Abstract][Full Text] [Related]
15. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
Lombardi V; Querin G; Ziff OJ; Zampedri L; Martinelli I; Heller C; Foiani M; Bertolin C; Lu CH; Malik B; Allen K; Rinaldi C; Zetterberg H; Heslegrave A; Greensmith L; Hanna M; Soraru G; Malaspina A; Fratta P
Neurology; 2019 Mar; 92(11):e1205-e1211. PubMed ID: 30787165
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic evaluation reveals thinning of cervical nerve roots and peripheral nerves in spinal and bulbar muscular atrophy.
Watanabe D; Tsukamoto H; Abe T; Kitao R; Okuma A; Mihara M; Katsumoto A; Iwahashi Y; Higashiyama Y; Miyaji Y; Joki H; Doi H; Komori T; Tanaka F
Neurol Sci; 2022 Jul; 43(7):4267-4274. PubMed ID: 35237894
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy.
Habets LE; Bartels B; Asselman FL; Hooijmans MT; van den Berg S; Nederveen AJ; van der Pol WL; Jeneson JAL
Brain; 2022 May; 145(4):1422-1435. PubMed ID: 34788410
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.
Rossor AM; Oates EC; Salter HK; Liu Y; Murphy SM; Schule R; Gonzalez MA; Scoto M; Phadke R; Sewry CA; Houlden H; Jordanova A; Tournev I; Chamova T; Litvinenko I; Zuchner S; Herrmann DN; Blake J; Sowden JE; Acsadi G; Rodriguez ML; Menezes MP; Clarke NF; Auer Grumbach M; Bullock SL; Muntoni F; Reilly MM; North KN
Brain; 2015 Feb; 138(Pt 2):293-310. PubMed ID: 25497877
[TBL] [Abstract][Full Text] [Related]
19. Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy.
Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Araki A; Watanabe H; Tanaka S; Yamamoto M; Sobue G
Neurology; 2014 Jan; 82(3):255-62. PubMed ID: 24353334
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA).
Suzuki K; Kastuno M; Banno H; Sobue G
Neuropathology; 2009 Aug; 29(4):509-16. PubMed ID: 19486304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
